SCHEMBL25825409

SCHEMBL25825409

O=C(O)c1ccc2nccc(Nc3ccc(C(=O)Nc4ccc(Nc5ccccc5)cc4)cn3)c2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 9/20 0.57
DNMT3A Q9Y6K1 7/20 0.57
DNMT3L Q9UJW3 4/20 0.57
HCAR3 P49019 2/20 0.51
KMT2A Q03164 2/20 0.51
USP2 O75604 1/20 0.51
MAPT P10636 1/20 0.51
MAPKAPK2 P49137 1/20 0.49
MEN1 O00255 1/20 0.49
EHMT1 Q9H9B1 2/20 0.48
MYC P01106 1/20 0.48
MAP2K3 P46734 1/20 0.48
EHMT2 Q96KQ7 1/20 0.48
DNMT3B Q9UBC3 1/20 0.48
AURKA O14965 1/20 0.48
AURKB Q96GD4 1/20 0.48
IP6K1 Q92551 1/20 0.47
IP6K3 Q96PC2 1/20 0.47
IP6K2 Q9UHH9 1/20 0.47
HDAC3 O15379 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19151333 0.93 MAPT (0.60) DNMT1DNMT3ADNMT3LHCAR3KMT2A
SCHEMBL25825406 0.90 DNMT1 (0.53) DNMT1DNMT3ADNMT3LHCAR3KMT2A
SCHEMBL25826601 0.90 DNMT1 (0.53) DNMT1DNMT3ADNMT3LKMT2AUSP2
SCHEMBL25825412 0.90 DNMT1 (0.55) DNMT1DNMT3ADNMT3LKMT2AUSP2
SCHEMBL25825393 0.89 DNMT1 (0.72) DNMT1DNMT3ADNMT3LKMT2AUSP2
SCHEMBL25825374 0.88 DNMT1 (0.53) DNMT1DNMT3ADNMT3LKMT2AUSP2
SCHEMBL25826583 0.88 DNMT1 (0.53) DNMT1DNMT3ADNMT3LKMT2AUSP2
SCHEMBL25825372 0.87 KMT2A (0.70) DNMT1DNMT3ADNMT3LKMT2AUSP2
SCHEMBL25825387 0.84 DNMT1 (0.58) DNMT1DNMT3ADNMT3LKMT2AUSP2
SCHEMBL22793632 0.84 MAPT (0.59) DNMT1DNMT3ADNMT3LKMT2AUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR DNMT1 4785/4885DNMT3A 4693/4885DNMT3L 4461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.